A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC Subjects
Clinical trial NCT03121716 · COMPLETED
Trial details
- NCT number
- NCT03121716
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-26
- Primary completion
- 2020-07-28
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.